Active, Not Recruiting
A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.
NCT05335993
- Conditions
- Adenocarcinoma of Ovary, Adnexal Diseases, Carcinoma, +25 more
- Locations
-
- Duke Cancer Center Durham, North Carolina, United States
- Stephenson Cancer Center- University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
- University of Virginia Health System Charlottesville, Virginia, United States